Trials / Conditions / Epstein-Barr Virus (EBV) Infection
Epstein-Barr Virus (EBV) Infection
4 registered clinical trials studyying Epstein-Barr Virus (EBV) Infection — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Application of PD-1 Inhibitors Combined With Tenofovir, Chidamide and Lenalidomide in the Treatment of EBV-ass NCT07133776 | The Affiliated Hospital of Xuzhou Medical University | Phase 1 / Phase 2 |
| Recruiting | A Phase Ib Study of VK-2019 in Patients With Relapsed or Refractory EBV+ Diffuse Large B-cell Lymphomas (DLBCL NCT06789159 | Thomas Jefferson University | Phase 1 |
| Recruiting | Occurrence of Antibodies Cross-reacting With Autoantigens in Primary EBV Infection NCT05127980 | University Hospital, Basel, Switzerland | — |
| Completed | Evaluation of Safety, Immune-Response and Efficacy of GSK Biologicals' EBV (Epstein Barr Virus) Vaccine (26866 NCT00430534 | Henogen | Phase 2 |